Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2016
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone MetastasisZahi Mitri, Rita Nanda, Kimberly Blackwell, et al.
Frontiers in Synaptic Neuroscience|October 30, 2018
Social Stimulus Causes Aberrant Activation of the Medial Prefrontal Cortex in a Mouse Model With Autism-Like BehaviorsAntonella Pirone, Jonathan M Alexander, Jenny B Koenig, et al.
Clinical Breast Cancer|April 28, 2015
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast CancerAna M Gonzalez-Angulo, Xiudong Lei, Richardo H Alvarez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
Which threshold for ER positivity? a retrospective study based on 9639 patientsM Yi, L Huo, K B Koenig, et al.
The Science of the Total Environment|August 31, 1999
Spatial and temporal trends of contaminants in Canadian Arctic freshwater and terrestrial ecosystems: a reviewB Braune, D Muir, B DeMarch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2020
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid TumorsAlexej Ballhausen, Jennifer J Wheler, Daniel D Karp, et al.
Breast Cancer Research and Treatment|June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancerBanu K Arun, Yun Gong, Diane Liu, et al.
JAMA Oncology|November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and BevacizumabReva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
Critical Care (London, England)|July 16, 2022
Neurologic manifestations of COVID-19 in critically ill patients: results of the prospective multicenter registry PANDEMICKonstantinos Dimitriadis, Jan Meis, Hermann Neugebauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†A M Gonzalez-Angulo, A Akcakanat, S Liu, et al.
Pageof 16